Novonix Research Development from 2010 to 2026

NVX Stock  USD 1.04  0.08  7.14%   
Novonix Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 5 M in 2026. During the period from 2010 to 2026, Novonix Research Development regression line of annual values had r-squared of  0.01 and arithmetic mean of  4,882,206. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
5.6 M
Current Value
M
Quarterly Volatility
911.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Other Operating Expenses of 69.3 M, Total Operating Expenses of 67.1 M or Depreciation And Amortization of 5.5 M, as well as many indicators such as Price To Sales Ratio of 68.15, Dividend Yield of 0.0167 or PTB Ratio of 2.51. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Build AI portfolio with Novonix Stock
Check out the analysis of Novonix Correlation against competitors.
The evolution of Research Development for Novonix Ltd ADR provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Novonix compares to historical norms and industry peers.

Latest Novonix's Research Development Growth Pattern

Below is the plot of the Research Development of Novonix Ltd ADR over the last few years. It is Novonix's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Very volatile
   Research Development   
       Timeline  

Novonix Research Development Regression Statistics

Arithmetic Mean4,882,206
Geometric Mean4,770,523
Coefficient Of Variation18.67
Mean Deviation550,748
Median5,102,824
Standard Deviation911,730
Sample Variance831.3B
Range3.4M
R-Value(0.09)
Mean Square Error878.8B
R-Squared0.01
Significance0.72
Slope(16,984)
Total Sum of Squares13.3T

Novonix Research Development History

2026M
20255.6 M
20244.8 M
20235.8 M
20222.8 M
20205.7 M
20192.4 M

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development5.6 MM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.